Since the withdrawal of Vioxx, experts have debated whether other NSAIDs have similar cardiovascular risks
October 2006
Since the withdrawal of Vioxx, experts have debated whether other NSAIDs have similar cardiovascular risks.
Now several new studies are shedding more light.
Vioxx (rofecoxib) seems especially risky...even low doses increase heart attack risk. And this risk is seen shortly after starting the drug...not just after 18 months as originally thought.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote